Marília Magalhães Cabral
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marília Magalhães Cabral has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ariclécio Cunha de Oliveira
Endocrine Physiology and Metabolism Laboratory, Superior Institute of Biomedical Sciences, State University of Ceará, Fortaleza 60714-903, Ceará, Brazil
3 shared publications - Keciany Alves de Oliveira
Higher Institute of Biomedical Sciences, State University of Ceara-UECE, Fortaleza 60714-903, CE, Brazil
3 shared publications - Antonio Augusto Ferreira Carioca
Universidade de Fortaleza, Brazil
2 shared publications - Gabriel Martins de Araújo Sousa
Laboratory of Endocrine Physiology and Metabolism, Superior Institute of Biomedical Sciences, State University of Ceará, Fortaleza, Ceará, 60714-903, Brazil
2 shared publications - Paula Alexandre de Freitas
Universidade Estadual do Ceará Instituto Superior de Ciências Biomédicas Laboratório de Fisiologia Endócrina e Metabolismo FortalezaCE Brasil Laboratório de Fisiologia Endócrina e Metabolismo, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Fortaleza, CE, Brasil
2 shared publications - Ana Cecília Pereira Dantas
Department of Nutrition, State University Ceara, Fortaleza, Brazil
1 shared publication
Latest Publications
- Open Access
Impacts of Yacon Syrup (Smallanthus sonchifolius) on Human Health: A Systematic Review of Scientific Evidence from the Last Decade
Background/Objectives: Yacon syrup (Smallanthus sonchifolius) has gained attention due to its high concentration of fructooligosaccharides (FOSs) and associated health benefits. This systematic review aimed to evaluate the effects of yacon syrup on metabolic parameters and intestinal health in humans over the last decade. Methods: Following PRISMA guidelines, we conducted a systematic search in databases, including Medline (PubMed), Science Direct, Embase, Scopus, and SciELO, up to October 2024. Inclusion criteria focused on clinical trials examining the impact of yacon syrup on glycemic control, lipid profile, insulin sensitivity, appetite regulation, and gut microbiota in healthy, overweight, or obese individuals. Seven studies met the inclusion criteria, encompassing 161 participants from diverse populations. Results: Yacon syrup supplementation demonstrated significant reductions in fasting insulin, HOMA-IR, and LDL cholesterol, alongside improvements in satiety and intestinal transit time. Acute supplementation with yacon syrup had inconsistent results for postprandial glycemia and insulin levels, probably due to prior individual gut microbiota composition. Longer interventions with yacon syrup were associated with enhanced microbiota modulation and appetite regulation, particularly in women. Mild gastrointestinal discomfort was reported, but with the continued use of yacon syrup, the symptoms decreased. Yacon syrup presents promising health benefits, including improved insulin sensitivity, weight management, and gut health. However, further research is needed to establish optimal dosing and long-term safety. Conclusions: This review highlights the potential of yacon syrup as a functional supplement for metabolic and gastrointestinal health.
Open AccessImpacts of Yacon Syrup (Smallanthus sonchifolius) on Human Health: A Systematic Review of Scientific Evidence from the Last Decade
Background/Objectives: Yacon syrup (Smallanthus sonchifolius) has gained attention due to its high concentration of fructooligosaccharides (FOSs) and associated health benefits. This systematic review aimed to evaluate the effects of yacon syrup on metabolic parameters and intestinal health in humans over the last decade. Methods: Following PRISMA guidelines, we conducted a systematic search in databases, including Medline (PubMed), Science Direct, Embase, Scopus, and SciELO, up to October 2024. Inclusion criteria focused on clinical trials examining the impact of yacon syrup on glycemic control, lipid profile, insulin sensitivity, appetite regulation, and gut microbiota in healthy, overweight, or obese individuals. Seven studies met the inclusion criteria, encompassing 161 participants from diverse populations. Results: Yacon syrup supplementation demonstrated significant reductions in fasting insulin, HOMA-IR, and LDL cholesterol, alongside improvements in satiety and intestinal transit time. Acute supplementation with yacon syrup had inconsistent results for postprandial glycemia and insulin levels, probably due to prior individual gut microbiota composition. Longer interventions with yacon syrup were associated with enhanced microbiota modulation and appetite regulation, particularly in women. Mild gastrointestinal discomfort was reported, but with the continued use of yacon syrup, the symptoms decreased. Yacon syrup presents promising health benefits, including improved insulin sensitivity, weight management, and gut health. However, further research is needed to establish optimal dosing and long-term safety. Conclusions: This review highlights the potential of yacon syrup as a functional supplement for metabolic and gastrointestinal health.
- Open Access
- 4 January 2024
- Published by Universidade Estadual do Ceará in Nutrivisa - Revista de Nutrição e Vigilância em Saúde
- Vol. 11 (1)
Yacon syrup supplementation improves cholesterol and body composition in overweight and obese women: a double-blind randomized clinical trial
Introduction: Obesity is a multifactorial chronic disease with high prevalence among women in Brazil. It can cause changes in glycemic, lipid and anthropometric profiles, bringing about adjacent diseases. Yacon syrup contains prebiotics that have been shown to have a positive effect on obesity originated diseases. Our study evaluated the effect of long-term use of yacon syrup on lipid, glycemic, anthropometric profiles and oxidative damage markers in overweight or obese women assisted in an university extension project. Materials and Methods: In this randomized, double-blind clinical trial, 15 adult women were allocated into yacon group (n=10) and control group (n=5). They consumed 12 mL of yacon syrup (5.3 g of fructooligosaccharides) and 12 mL of maltodextrin syrup (placebo) for 30 days, after breakfast, and followed an individualized food plan. Blood samples were collected and an anthropometric assessment was performed before (D1) and after (D2) the 30 days of intervention. Results and discussion : There was no significant change in fasting blood glucose in any of the evaluated groups (P<0,05). There was a decrease in the amount of body fat, cholesterol and 8-isoprostane after 30 days of yacon syrup supplementation (P<0,05). Conclusion: Chronic yacon syrup had no effect on the glycemic profile, but decreased total cholesterol, body fat and 8-isoprostane levels in overweight or obese women.
- 4 January 2024
- Published by Universidade Estadual do Ceará in Nutrivisa - Revista de Nutrição e Vigilância em Saúde
- Vol. 11 (1)
Open AccessYacon syrup supplementation improves cholesterol and body composition in overweight and obese women: a double-blind randomized clinical trial
Introduction: Obesity is a multifactorial chronic disease with high prevalence among women in Brazil. It can cause changes in glycemic, lipid and anthropometric profiles, bringing about adjacent diseases. Yacon syrup contains prebiotics that have been shown to have a positive effect on obesity originated diseases. Our study evaluated the effect of long-term use of yacon syrup on lipid, glycemic, anthropometric profiles and oxidative damage markers in overweight or obese women assisted in an university extension project. Materials and Methods: In this randomized, double-blind clinical trial, 15 adult women were allocated into yacon group (n=10) and control group (n=5). They consumed 12 mL of yacon syrup (5.3 g of fructooligosaccharides) and 12 mL of maltodextrin syrup (placebo) for 30 days, after breakfast, and followed an individualized food plan. Blood samples were collected and an anthropometric assessment was performed before (D1) and after (D2) the 30 days of intervention. Results and discussion : There was no significant change in fasting blood glucose in any of the evaluated groups (P<0,05). There was a decrease in the amount of body fat, cholesterol and 8-isoprostane after 30 days of yacon syrup supplementation (P<0,05). Conclusion: Chronic yacon syrup had no effect on the glycemic profile, but decreased total cholesterol, body fat and 8-isoprostane levels in overweight or obese women.
- Open Access
- 16 February 2022
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 10 (1) , 1-7
ARTIGO DE REVISÃO O uso do guaraná (Paulinia cupana) como suplemento dietético antienvelhecimento: uma revisão sistemática
Objetivo: o presente estudo busca avaliar se o guaraná poderia ser utilizado no antienvelhecimento. Métodos: foi realizada uma revisão sistemática de acordo com as normas do PRISMA. As bases de dados utilizadas foram Scielo e Medline (PUBMED). Foram incluídos artigos originais publicados entre 2016 e 2021 que avaliem os efeitos da suplementação do guaraná sobre os marcadores do envelhecimento. Foi realizada a avaliação de risco de viés pelo SYRCLE. Oito publicações foram incluídas nesta revisão após a análise dos critérios de inclusão e exclusão. Resultados: o guaraná aumentou a expectativa de vida e reduziu os marcadores de envelhecimento pelo seu efeito antioxidante. O guaraná preveniu o ganho de peso, a resistência à insulina, a desregulação de adipocinas, estimulou a biogênese mitocondrial e apresentou atividade anti-inflamatória. Assim, a ativação do tecido adiposo parece ser um dos mecanismos de ação envolvidos na suplementação de guaraná como antienvelhecimento. Contudo, a maioria dos estudos tiveram alto risco de viés, quanto ao uso do guaraná no retardo das alterações associadas ao envelhecimento. Conclusão: desta forma, para que se tenha uma recomendação da aplicabilidade do guaraná, faz-se necessária a realização de mais estudos com melhor qualidade metodológica.
- 16 February 2022
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 10 (1) , 1-7
Open AccessARTIGO DE REVISÃO O uso do guaraná (Paulinia cupana) como suplemento dietético antienvelhecimento: uma revisão sistemática
Objetivo: o presente estudo busca avaliar se o guaraná poderia ser utilizado no antienvelhecimento. Métodos: foi realizada uma revisão sistemática de acordo com as normas do PRISMA. As bases de dados utilizadas foram Scielo e Medline (PUBMED). Foram incluídos artigos originais publicados entre 2016 e 2021 que avaliem os efeitos da suplementação do guaraná sobre os marcadores do envelhecimento. Foi realizada a avaliação de risco de viés pelo SYRCLE. Oito publicações foram incluídas nesta revisão após a análise dos critérios de inclusão e exclusão. Resultados: o guaraná aumentou a expectativa de vida e reduziu os marcadores de envelhecimento pelo seu efeito antioxidante. O guaraná preveniu o ganho de peso, a resistência à insulina, a desregulação de adipocinas, estimulou a biogênese mitocondrial e apresentou atividade anti-inflamatória. Assim, a ativação do tecido adiposo parece ser um dos mecanismos de ação envolvidos na suplementação de guaraná como antienvelhecimento. Contudo, a maioria dos estudos tiveram alto risco de viés, quanto ao uso do guaraná no retardo das alterações associadas ao envelhecimento. Conclusão: desta forma, para que se tenha uma recomendação da aplicabilidade do guaraná, faz-se necessária a realização de mais estudos com melhor qualidade metodológica.